CHARLES F LEVENBACK

TitleProfessor
InstitutionMD Anderson
DepartmentGynecological Oncology & Reproductive Medicine
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chelariu-Raicu A, Levenback CF, Slomovitz BM, Wolf J, Bodurka DC, Kavanagh JJ, Morrison C, Gershenson DM, Coleman RL. Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer. Int J Gynecol Cancer. 2020 Nov; 30(11):1768-1774. PMID: 33037105.
      Citations:    Fields:    
    2. Marcus RK, Lillemoe HA, Caudle AS, Weinberg JS, Gidley PW, Skibber JM, Levenback CF, Swisher SG, Aloia TA. Facilitation of Surgical Innovation: Is It Possible to Speed the Introduction of New Technology While Simultaneously Improving Patient Safety? Ann Surg. 2019 12; 270(6):937-941. PMID: 30946086.
      Citations:    Fields:    Translation:Humans
    3. Narula N, Lillemoe HA, Caudle AS, Chemaly RF, Anderson JJ, Segal C, Porter CA, Swisher SG, Levenback CF, Aloia TA. Postoperative Urinary Tract Infection Quality Assessment and Improvement: The S.T.O.P. UTI Program and Its Impact on Hospitalwide CAUTI Rates. Jt Comm J Qual Patient Saf. 2019 10; 45(10):686-693. PMID: 31371099.
      Citations:    Fields:    Translation:Humans
    4. Prescott LS, Taylor JS, Enbaya A, Marten CA, Myers KN, Meyer LA, Ramirez PT, Levenback CF, Bodurka DC, Schmeler KM. Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology. Gynecol Oncol. 2019 06; 153(3):597-603. PMID: 30872025.
      Citations: 1     Fields:    Translation:Humans
    5. Slomovitz BM, Taub MC, Huang M, Levenback C, Coleman RL. A randomized phase II study of letrozole vs. observation in patients with newly diagnosed uterine leiomyosarcoma (uLMS). Gynecol Oncol Rep. 2019 Feb; 27:1-4. PMID: 30519622.
      Citations:    
    6. Soliman PT, Westin SN, Dioun S, Sun CC, Euscher E, Munsell MF, Fleming ND, Levenback C, Frumovitz M, Ramirez PT, Lu KH. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol. 2017 08; 146(2):234-239. PMID: 28528918.
      Citations: 14     Fields:    Translation:Humans
    7. Salvo G, Ramirez PT, Levenback CF, Munsell MF, Euscher ED, Soliman PT, Frumovitz M. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017 04; 145(1):96-101. PMID: 28188015.
      Citations: 14     Fields:    Translation:Humans
    8. Wang Z, Shi N, Naing A, Janku F, Subbiah V, Araujo DM, Patel SR, Ludwig JA, Ramondetta LM, Levenback CF, Ramirez PT, Piha-Paul SA, Hong D, Karp DD, Tsimberidou AM, Meric-Bernstam F, Fu S. Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience. Cancer Med. 2016 12; 5(12):3437-3444. PMID: 27882721.
      Citations: 6     Fields:    Translation:Humans
    9. Nagarajan P, Curry JL, Ning J, Piao J, Torres-Cabala CA, Aung PP, Ivan D, Ross MI, Levenback CF, Frumovitz M, Gershenwald JE, Davies MA, Malpica A, Prieto VG, Tetzlaff MT. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases. Clin Cancer Res. 2017 04 15; 23(8):2093-2104. PMID: 27864417.
      Citations: 7     Fields:    Translation:Humans
    10. Meyer LA, Cronin AM, Sun CC, Bixel K, Bookman MA, Cristea MC, Griggs JJ, Levenback CF, Burger RA, Mantia-Smaldone G, Matulonis UA, Niland JC, O'Malley DM, Wright AA. Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2016 11 10; 34(32):3854-3863. PMID: 27601552.
      Citations: 20     Fields:    Translation:Humans
    11. Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Cristea M, Griggs JJ, Levenback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun C, O'Malley DM, Wright AA. Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer. JAMA Oncol. 2016 Nov 01; 2(11):1427-1433. PMID: 27442965.
      Citations: 9     Fields:    Translation:Humans
    12. Taylor JS, Marten CA, Potts KA, Cloutier LM, Cain KE, Fenton SL, Tatum TN, James DA, Myers KN, Hubbs CA, Burzawa JK, Vachhani S, Nick AM, Meyer LA, Graviss LS, Ware KM, Park AK, Aloia TA, Bodurka DC, Levenback CF, Schmeler KM. What Is the Real Rate of Surgical Site Infection? J Oncol Pract. 2016 10; 12(10):e878-e883. PMID: 27460495.
      Citations: 1     Fields:    Translation:Humans
    13. Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KM. The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology. Ann Surg Oncol. 2017 Feb; 24(2):362-368. PMID: 27573526.
      Citations: 2     Fields:    Translation:Humans
    14. Ramirez PT, Levenback C. Long-term outcomes of sentinel node mapping in vulvar cancer: A time to cheer with enthusiasm or pause and question current practice? Gynecol Oncol. 2016 Jan; 140(1):1-2. PMID: 26724493.
      Citations: 1     Fields:    Translation:Humans
    15. Prescott LS, Dickens AS, Guerra SL, Tanha JM, Phillips DG, Patel KT, Umberson KM, Lozano MA, Lowe KB, Brown AJ, Taylor JS, Soliman PT, Garcia EA, Levenback CF, Bodurka DC. Fighting cancer together: Development and implementation of shared medical appointments to standardize and improve chemotherapy education. Gynecol Oncol. 2016 Jan; 140(1):114-9. PMID: 26549108.
      Citations: 4     Fields:    Translation:Humans
    16. Wright AA, Cronin A, Milne DE, Bookman MA, Burger RA, Cohn DE, Cristea MC, Griggs JJ, Keating NL, Levenback CF, Mantia-Smaldone G, Matulonis UA, Meyer LA, Niland JC, Weeks JC, O'Malley DM. Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2015 Sep 10; 33(26):2841-7. PMID: 26240233.
      Citations: 45     Fields:    Translation:Humans
    17. Subbiah V, McMahon C, Patel S, Zinner R, Silva EG, Elvin JA, Subbiah IM, Ohaji C, Ganeshan DM, Anand D, Levenback CF, Berry J, Brennan T, Chmielecki J, Chalmers ZR, Mayfield J, Miller VA, Stephens PJ, Ross JS, Ali SM. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion. J Hematol Oncol. 2015 Jun 11; 8:66. PMID: 26062823.
      Citations: 22     Fields:    Translation:Humans
    18. Slomovitz BM, Coleman RL, Oonk MH, van der Zee A, Levenback C. Update on sentinel lymph node biopsy for early-stage vulvar cancer. Gynecol Oncol. 2015 Aug; 138(2):472-7. PMID: 26022527.
      Citations: 6     Fields:    Translation:Humans
    19. Slomovitz BM, Jiang Y, Yates MS, Soliman PT, Johnston T, Nowakowski M, Levenback C, Zhang Q, Ring K, Munsell MF, Gershenson DM, Lu KH, Coleman RL. Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma. J Clin Oncol. 2015 Mar 10; 33(8):930-6. PMID: 25624430.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    20. Prescott LS, Kidin LM, Downs RL, Cleveland DJ, Wilson GL, Munsell MF, DeJesus AY, Cain KE, Ramirez PT, Kroll MH, Levenback CF, Schmeler KM. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence. Int J Gynecol Cancer. 2015 Jan; 25(1):152-9. PMID: 25365592.
      Citations:    Fields:    Translation:Humans
    21. Brown AJ, Sun CC, Urbauer D, Zhukovsky DS, Levenback C, Frumovitz M, Thaker PH, Bodurka DC, Ramondetta LM. Targeting those with decreased meaning and peace: a supportive care opportunity. Support Care Cancer. 2015 Jul; 23(7):2025-32. PMID: 25519758.
      Citations: 3     Fields:    Translation:Humans
    22. Prescott LS, Aloia TA, Brown AJ, Taylor JS, Munsell MF, Sun CC, Schmeler KM, Levenback CF, Bodurka DC. Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database. Gynecol Oncol. 2015 Jan; 136(1):65-70. PMID: 25451693.
      Citations: 10     Fields:    Translation:Humans
    23. Piha-Paul SA, Wheler JJ, Fu S, Levenback C, Lu K, Falchook GS, Naing A, Hong DS, Tsimberidou AM, Kurzrock R. Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus. Oncotarget. 2014 Apr 15; 5(7):1846-55. PMID: 24742900.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    24. Holman LL, Levenback CF, Frumovitz M. Sentinel lymph node evaluation in women with cervical cancer. J Minim Invasive Gynecol. 2014 Jul-Aug; 21(4):540-5. PMID: 24407177.
      Citations: 10     Fields:    Translation:Humans
    25. Frumovitz M, Coleman RC, Soliman PT, Ramirez PT, Levenback CF. A case for caution in the pursuit of the sentinel node in women with endometrial carcinoma. Gynecol Oncol. 2014 Feb; 132(2):275-9. PMID: 24291694.
      Citations: 6     Fields:    Translation:Humans
    26. Cohn DE, Leitao M, Levenback C, Berkowitz R, Roman L, Lucci J, Kim S, Lancaster J, Odunsi K, Wakabayashi M, Goff BA. Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative. Gynecol Oncol. 2013 Sep; 130(3):403-6. PMID: 23718934.
      Citations: 3     Fields:    Translation:Humans
    27. Takiar V, Fontanilla HP, Eifel PJ, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Klopp A. Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):1045-50. PMID: 23332221.
      Citations: 6     Fields:    Translation:Humans
    28. Coleman RL, Ali S, Levenback CF, Gold MA, Fowler JM, Judson PL, Bell MC, De Geest K, Spirtos NM, Potkul RK, Leitao MM, Bakkum-Gamez JN, Rossi EC, Lentz SS, Burke JJ, Van Le L, Trimble CL. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013 Feb; 128(2):155-9. PMID: 23201592.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    29. Schmeler KM, Wilson GL, Cain K, Munsell MF, Ramirez PT, Soliman PT, Nick AM, Frumovitz M, Coleman RL, Kroll MH, Levenback CF. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecol Oncol. 2013 Feb; 128(2):204-8. PMID: 23200912.
      Citations: 13     Fields:    Translation:Humans
    30. Moroney J, Fu S, Moulder S, Falchook G, Helgason T, Levenback C, Hong D, Naing A, Wheler J, Kurzrock R. Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity. Clin Cancer Res. 2012 Oct 15; 18(20):5796-805. PMID: 22927482.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    31. Frumovitz M, Euscher ED, Deavers MT, Soliman PT, Schmeler KM, Ramirez PT, Levenback CF. "Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer. Gynecol Oncol. 2012 Dec; 127(3):467-71. PMID: 22910691.
      Citations: 5     Fields:    Translation:Humans
    32. Cain K, Schmeler KM, Langley G, Max O, Ramirez PT, Levenback CF. Patient cost associated with filling a prescription for extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic cancer. Gynecol Oncol. 2012 Oct; 127(1):18-21. PMID: 22813886.
      Citations: 5     Fields:    Translation:Humans
    33. Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL, Bell MC, De Geest K, Spirtos NM, Potkul RK, Leitao MM, Bakkum-Gamez JN, Rossi EC, Lentz SS, Burke JJ, Van Le L, Trimble CL. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012 Nov 01; 30(31):3786-91. PMID: 22753905.
      Citations: 40     Fields:    Translation:HumansCTClinical Trials
    34. Zand B, Frumovitz M, Jofre MF, Nick AM, Dos Reis R, Munsell MF, Sangi-Haghpeykar H, Levenback C, Soliman PT, Schmeler KM, Ramirez PT. Risk factors for prolonged hospitalization after gynecologic laparoscopic surgery. Gynecol Oncol. 2012 Sep; 126(3):428-31. PMID: 22668880.
      Citations: 3     Fields:    Translation:Humans
    35. Fu S, Hennessy BT, Ng CS, Ju Z, Coombes KR, Wolf JK, Sood AK, Levenback CF, Coleman RL, Kavanagh JJ, Gershenson DM, Markman M, Dice K, Howard A, Li J, Li Y, Stemke-Hale K, Dyer M, Atkinson E, Jackson E, Kundra V, Kurzrock R, Bast RC, Mills GB. Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. Gynecol Oncol. 2012 Jul; 126(1):47-53. PMID: 22487539.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    36. Fontanilla HP, Klopp AH, Lindberg ME, Jhingran A, Kelly P, Takiar V, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol. 2013 Jan-Mar; 3(1):45-53. PMID: 24674263.
      Citations: 2     Fields:    
    37. Noguera IR, Sun CC, Broaddus RR, Branham D, Levenback CF, Ramirez PT, Sood AK, Coleman RL, Gershenson DM. Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube. Gynecol Oncol. 2012 Jun; 125(3):640-5. PMID: 22387451.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    38. Worley MJ, Anwandter C, Sun CC, dos Reis R, Nick AM, Frumovitz M, Soliman PT, Schmeler KM, Levenback CF, Munsell MF, Ramirez PT. Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery. Gynecol Oncol. 2012 Apr; 125(1):241-4. PMID: 22240566.
      Citations: 1     Fields:    Translation:Humans
    39. Viswanathan AN, Moughan J, Small W, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer. 2012 Jan; 22(1):123-31. PMID: 22193645.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    40. Small W, Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, Gaffney D, Erickson B, Greven K. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. Int J Gynecol Cancer. 2011 Oct; 21(7):1266-75. PMID: 21892091.
      Citations: 8     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    41. Soliman PT, Frumovitz M, Sun CC, Dos Reis R, Schmeler KM, Nick AM, Westin SN, Brown J, Levenback CF, Ramirez PT. Radical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol. 2011 Nov; 123(2):333-6. PMID: 21872911.
      Citations: 27     Fields:    Translation:Humans
    42. Ramondetta LM, Urbauer D, Brown AJ, Richardson G, Thaker PH, Koenig HG, Levenback C, Sun C. Work related stress among gynecologic oncologists. Gynecol Oncol. 2011 Nov; 123(2):365-9. PMID: 21777966.
      Citations: 2     Fields:    Translation:Humans
    43. Markman M, Sehouli J, Levenback CF, Chi DS. Epithelial ovarian cancer: focus on targeted therapy. J Oncol. 2010; 2010:171425. PMID: 21804823.
      Citations:    
    44. Leong SP, Zuber M, Ferris RL, Kitagawa Y, Cabanas R, Levenback C, Faries M, Saha S. Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. J Surg Oncol. 2011 May 01; 103(6):518-30. PMID: 21480244.
      Citations: 14     Fields:    Translation:Humans
    45. Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifel PJ, Levenback CF, Ramirez PT. Primary malignant melanoma of the vagina. Obstet Gynecol. 2010 Dec; 116(6):1358-65. PMID: 21099603.
      Citations: 21     Fields:    Translation:Humans
    46. Fu S, Hu W, Iyer R, Kavanagh JJ, Coleman RL, Levenback CF, Sood AK, Wolf JK, Gershenson DM, Markman M, Hennessy BT, Kurzrock R, Bast RC. Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer. Cancer. 2011 Apr 15; 117(8):1661-9. PMID: 21472713.
      Citations: 62     Fields:    Translation:HumansCellsCTClinical Trials
    47. Brown J, Smith JA, Ramondetta LM, Sood AK, Ramirez PT, Coleman RL, Levenback CF, Munsell MF, Jung M, Wolf JK. Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial. Cancer. 2010 Nov 01; 116(21):4973-9. PMID: 20665499.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    48. Soliman PT, Frumovitz M, Spannuth W, Greer MJ, Sharma S, Schmeler KM, Ramirez PT, Levenback CF, Ramondetta LM. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010 Nov; 119(2):291-4. PMID: 20708226.
      Citations: 28     Fields:    Translation:Humans
    49. Bhosale P, Peungjesada S, Wei W, Levenback CF, Schmeler K, Rohren E, Macapinlac HA, Iyer RB. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Int J Gynecol Cancer. 2010 Aug; 20(6):936-44. PMID: 20683399.
      Citations: 9     Fields:    Translation:Humans
    50. Levenback C. New or not? Difficulties recognizing innovation. Gynecol Oncol. 2010 Jun; 117(3):399-400. PMID: 20466124.
      Citations:    Fields:    Translation:Humans
    51. Levenback CF. How important is size of sentinel lymph-node metastases in patients with vulvar cancer? Lancet Oncol. 2010 Jul; 11(7):607-8. PMID: 20537951.
      Citations:    Fields:    Translation:Humans
    52. Chi DS, Barlin JN, Ramirez PT, Levenback CF, Mironov S, Sarasohn DM, Iyer RB, Dao F, Hricak H, Barakat RR. Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller. Int J Gynecol Cancer. 2010 Apr; 20(3):353-7. PMID: 20375796.
      Citations: 2     Fields:    Translation:Humans
    53. Kavanagh JJ, Levenback CF, Ramirez PT, Wolf JL, Moore CL, Jones MR, Meng L, Brown GL, Bast RC. Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer. J Hematol Oncol. 2010 Mar 11; 3:9. PMID: 20222977.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    54. Kobayashi K, Ramirez PT, Kim EE, Levenback CF, Rohren EM, Frumovitz M, Mar MV, Gayed IW. Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy. Clin Nucl Med. 2009 Dec; 34(12):859-61. PMID: 20139817.
      Citations: 6     Fields:    Translation:Humans
    55. Cheng X, Moroney JW, Levenback CF, Fu S, Jaishuen A, Kavanagh JJ. What is the benefit of bevacizumab combined with chemotherapy in patients with recurrent ovarian, fallopian tube or primary peritoneal malignancies? J Chemother. 2009 Nov; 21(5):566-72. PMID: 19933049.
      Citations: 6     Fields:    Translation:Humans
    56. Levenback CF, van der Zee AG, Rob L, Plante M, Covens A, Schneider A, Coleman R, Solima E, Hertel H, Barranger E, Obermair A, Roy M. Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol Oncol. 2009 Aug; 114(2):151-6. PMID: 19457548.
      Citations: 10     Fields:    Translation:Humans
    57. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter? Int J Gynecol Cancer. 2009 Aug; 19(6):1107-12. PMID: 19820377.
      Citations: 2     Fields:    Translation:Humans
    58. Frumovitz M, Sun CC, Schmeler KM, Deavers MT, Dos Reis R, Levenback CF, Ramirez PT. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009 Jul; 114(1):93-9. PMID: 19546764.
      Citations: 28     Fields:    Translation:Humans
    59. Schmeler KM, Vadhan-Raj S, Ramirez PT, Apte SM, Cohen L, Bassett RL, Iyer RB, Wolf JK, Levenback CL, Gershenson DM, Freedman RS. A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer. Gynecol Oncol. 2009 May; 113(2):210-5. PMID: 19264351.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    60. Hunter RJ, Pace MB, Burns KA, Burke CC, Gonzales DA, Webb NF, Levenback CF, Jhingran A, Parker C, Munsell MF, Smith JA. Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment. Support Care Cancer. 2009 Sep; 17(9):1195-201. PMID: 19172305.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    61. Eifel PJ, Jhingran A, Levenback CF, Tucker S. Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer. 2009 Jan; 19(1):2-7. PMID: 19258933.
      Citations: 6     Fields:    Translation:Humans
    62. Jandial DD, Soliman PT, Slomovitz BM, Schmeler KM, Levenback C, Coleman RL, Ramirez PT. Laparoscopic colostomy in gynecologic cancer. J Minim Invasive Gynecol. 2008 Nov-Dec; 15(6):723-8. PMID: 18971136.
      Citations:    Fields:    Translation:Humans
    63. Levenback C. Update on sentinel lymph node biopsy in gynecologic cancers. Gynecol Oncol. 2008 Nov; 111(2 Suppl):S42-3. PMID: 18804266.
      Citations: 4     Fields:    Translation:Humans
    64. Euscher ED, Malpica A, Atkinson EN, Levenback CF, Frumovitz M, Deavers MT. Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. Am J Surg Pathol. 2008 Sep; 32(9):1336-43. PMID: 18670356.
      Citations: 12     Fields:    Translation:Humans
    65. Obermair A, Gebski V, Frumovitz M, Soliman PT, Schmeler KM, Levenback C, Ramirez PT. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008 Sep-Oct; 15(5):584-8. PMID: 18722970.
      Citations: 33     Fields:    Translation:HumansCTClinical Trials
    66. Frumovitz M, Ramirez PT, Levenback CF. Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S17-20. PMID: 18502488.
      Citations: 10     Fields:    Translation:Humans
    67. Frumovitz M, Levenback CF. Is lymphatic mapping in uterine cancer feasible? Ann Surg Oncol. 2008 Jul; 15(7):1815-7. PMID: 18473144.
      Citations: 2     Fields:    Translation:Humans
    68. Ramirez PT, Schmeler KM, Milam MR, Slomovitz BM, Smith JA, Kavanagh JJ, Deavers M, Levenback C, Coleman RL, Gershenson DM. Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum. Gynecol Oncol. 2008 Jul; 110(1):56-9. PMID: 18457865.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    69. Frumovitz M, Levenback CF. Lymphatic mapping and sentinel node biopsy in vulvar, vaginal, and cervical cancers. Oncology (Williston Park). 2008 Apr 30; 22(5):529-36; discussion 538-9, 542-3. PMID: 18533402.
      Citations: 4     Fields:    Translation:Humans
    70. Levenback CF. How safe is sentinel lymph node biopsy in patients with vulvar cancer? J Clin Oncol. 2008 Feb 20; 26(6):828-9. PMID: 18281651.
      Citations: 2     Fields:    Translation:Humans
    71. Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CF. Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol. 2008 Mar; 108(3):478-81. PMID: 18190952.
      Citations: 4     Fields:    Translation:Humans
    72. Levenback CF. Status of sentinel lymph node biopsy in gynecological cancers. Ann Surg Oncol. 2008 Jan; 15(1):18-20. PMID: 17943389.
      Citations: 2     Fields:    Translation:Humans
    73. Ramirez PT, Landen CN, Coleman RL, Milam MR, Levenback C, Johnston TA, Gershenson DM. Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer. Gynecol Oncol. 2008 Jan; 108(1):68-71. PMID: 17905421.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    74. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys. 2008 Jan 01; 70(1):118-25. PMID: 17869451.
      Citations: 9     Fields:    Translation:Humans
    75. Levenback CF. Status of sentinel lymph nodes in cervical cancer. Gynecol Oncol. 2007 Oct; 107(1 Suppl 1):S18-9. PMID: 17761270.
      Citations: 1     Fields:    Translation:Humans
    76. Ramirez PT, Frumovitz M, Dos Reis R, Milam MR, Bevers MW, Levenback CF, Coleman RL. Modified uterine manipulator and vaginal rings for total laparoscopic radical hysterectomy. Int J Gynecol Cancer. 2008 May-Jun; 18(3):571-5. PMID: 17692091.
      Citations: 2     Fields:    Translation:Humans
    77. Levenback CF. Has the time come for sentinel lymph node biopsy alone in radical hysterectomy patients? Gynecol Oncol. 2007 May; 105(2):283-4. PMID: 17448795.
      Citations:    Fields:    Translation:Humans
    78. Small W, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1081-7. PMID: 17398031.
      Citations: 28     Fields:    Translation:Humans
    79. Crotzer DR, Sun CC, Coleman RL, Wolf JK, Levenback CF, Gershenson DM. Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary. Gynecol Oncol. 2007 May; 105(2):404-8. PMID: 17292461.
      Citations: 43     Fields:    Translation:Humans
    80. Crotzer DR, Wolf JK, Gano JB, Gershenson DM, Levenback C. A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary. Gynecol Oncol. 2007 May; 105(2):399-403. PMID: 17292457.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    81. Zighelboim I, Ramirez PT, Gao F, Slomovitz BM, Sun C, Frumovitz M, Jhingran A, Levenback C. Retroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol. 2006 Aug; 15(2):79-83. PMID: 17035002.
      Citations: 1     Fields:    Translation:Humans
    82. Frumovitz M, Bodurka DC, Broaddus RR, Coleman RL, Sood AK, Gershenson DM, Burke TW, Levenback CF. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol. 2007 Jan; 104(1):100-3. PMID: 16963111.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    83. Ramirez PT, Slomovitz BM, McQuinn L, Levenback C, Coleman RL. Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer. Gynecol Oncol. 2006 Dec; 103(3):888-90. PMID: 16806436.
      Citations: 4     Fields:    Translation:Humans
    84. Coleman RL, Frumovitz M, Levenback CF. Current perspectives on lymphatic mapping in carcinomas of the uterine corpus and cervix. J Natl Compr Canc Netw. 2006 May; 4(5):471-8. PMID: 16687095.
      Citations: 1     Fields:    Translation:Humans
    85. Eifel PJ, Jhingran A, Brown J, Levenback C, Thames H. Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1106-11. PMID: 16803493.
      Citations: 4     Fields:    Translation:Humans
    86. Maluf FC, Leiser AL, Aghajanian C, Sabbatini P, Pezzulli S, Chi DS, Wolf JK, Levenback C, Loh E, Spriggs DR. Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1165-71. PMID: 16803501.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    87. Apte SM, Vadhan-Raj S, Cohen L, Bassett RL, Gordon IO, Levenback CF, Ramirez PT, Gallardo ST, Patenia RS, Garcia ME, Iyer RB, Freedman RS. Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin. J Transl Med. 2006 Apr 07; 4:16. PMID: 16603073.
      Citations: 6     Fields:    
    88. Frumovitz M, Coleman RL, Gayed IW, Ramirez PT, Wolf JK, Gershenson DM, Levenback CF. Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer. Am J Obstet Gynecol. 2006 Apr; 194(4):1186-93; discussion 1193-5. PMID: 16580331.
      Citations: 5     Fields:    Translation:Humans
    89. Slomovitz BM, Ramirez PT, Frumovitz M, Soliman PT, Bevers M, Coleman RL, Levenback C. Electrothermal bipolar coagulation for pelvic exenterations. Gynecol Oncol. 2006 Sep; 102(3):534-6. PMID: 16483643.
      Citations: 3     Fields:    Translation:Humans
    90. Ramirez PT, Slomovitz BM, Soliman PT, Coleman RL, Levenback C. Total laparoscopic radical hysterectomy and lymphadenectomy: the M. D. Anderson Cancer Center experience. Gynecol Oncol. 2006 Aug; 102(2):252-5. PMID: 16472844.
      Citations: 25     Fields:    Translation:Humans
    91. Coleman RL, Broaddus RR, Bodurka DC, Wolf JK, Burke TW, Kavanagh JJ, Levenback CF, Gershenson DM. Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers. Gynecol Oncol. 2006 Apr; 101(1):126-31. PMID: 16271384.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    92. Frumovitz M, Ramirez PT, Levenback C. Lymphatic mapping and sentinel node detection in gynecologic malignancies of the lower genital tract. Curr Oncol Rep. 2005 Nov; 7(6):435-43. PMID: 16221380.
      Citations:    Fields:    Translation:Humans
    93. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005 Oct 20; 23(30):7428-36. PMID: 16234510.
      Citations: 87     Fields:    Translation:Humans
    94. Valbuena JR, Levenback C, Mansfield P, Liu J. Angiosarcoma of the spleen clinically presenting as metastatic ovarian cancer. A case report and review of the literature. Ann Diagn Pathol. 2005 Oct; 9(5):289-92. PMID: 16198958.
      Citations: 13     Fields:    Translation:Humans
    95. Jenkins AD, Ramondetta LM, Sun C, Johnston T, Wolf JK, Bodurka DC, Brown J, Atkinson EN, Levenback C. Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 2005 Jun; 97(3):840-4. PMID: 15882895.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    96. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys. 2005 May 01; 62(1):138-47. PMID: 15850914.
      Citations: 23     Fields:    Translation:Humans
    97. Sood AK, Cooper BC, Sorosky JI, Ramirez PT, Levenback C. Novel modification of the vertical rectus abdominis myocutaneous flap for neovagina creation. Obstet Gynecol. 2005 Mar; 105(3):514-8. PMID: 15738017.
      Citations: 4     Fields:    Translation:Humans
    98. Levenback C. Selective sentinel lymphadenectomy for gynecologic cancer. Cancer Treat Res. 2005; 127:167-85. PMID: 16209083.
      Citations:    Fields:    Translation:Humans
    99. Ramirez PT, Frumovitz M, Wolf JK, Levenback C. Laparoscopic port-site metastases in patients with gynecological malignancies. Int J Gynecol Cancer. 2004 Nov-Dec; 14(6):1070-7. PMID: 15571612.
      Citations: 16     Fields:    Translation:Humans
    100. Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004 Oct; 95(1):133-8. PMID: 15385122.
      Citations: 59     Fields:    Translation:Humans
    101. Tangjitgamol S, See HT, Manusirivithaya S, Levenback CF, Gershenson DM, Kavanagh JJ. Third-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients. Int J Gynecol Cancer. 2004 Sep-Oct; 14(5):804-14. PMID: 15361188.
      Citations: 3     Fields:    Translation:Humans
    102. Frumovitz M, Ramirez PT, Greer M, Gregurich MA, Wolf J, Bodurka DC, Levenback C. Laparoscopic training and practice in gynecologic oncology among Society of Gynecologic Oncologists members and fellows-in-training. Gynecol Oncol. 2004 Sep; 94(3):746-53. PMID: 15350368.
      Citations: 12     Fields:    Translation:Humans
    103. Ramirez PT, Levenback C. Radical trachelectomy: is it here to stay? Gynecol Oncol. 2004 Sep; 94(3):611-3. PMID: 15350348.
      Citations: 1     Fields:    Translation:Humans
    104. Wolf JK, Bodurka DC, Gano JB, Deavers M, Ramondetta L, Ramirez PT, Levenback C, Gershenson DM. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. Gynecol Oncol. 2004 Aug; 94(2):442-8. PMID: 15297186.
      Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
    105. Ramondetta LM, Tortolero-Luna G, Bodurka DC, Sills D, Basen-Engquist K, Gano J, Levenback C. Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study. Int J Gynecol Cancer. 2004 Jul-Aug; 14(4):580-8. PMID: 15304150.
      Citations: 4     Fields:    Translation:Humans
    106. Donato ML, Aleman A, Champlin RE, Saliba RM, Wharton JT, Burke TW, Bodurka DC, Bevers MW, Levenback CF, Wolf JK, Bast RC, Freedman RS, Ippoliti C, Brewer M, Gajewski JL, Gershenson DM. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant. 2004 Jun; 33(12):1219-24. PMID: 15122311.
      Citations: 5     Fields:    Translation:Humans
    107. Tangjitgamol S, Levenback CF, Beller U, Kavanagh JJ. Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. Int J Gynecol Cancer. 2004 May-Jun; 14(3):399-422. PMID: 15228413.
      Citations: 17     Fields:    Translation:Humans
    108. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol. 2004 Apr; 93(1):27-33. PMID: 15047210.
      Citations: 40     Fields:    Translation:Humans
    109. van der Velden J, Ansink A. In regards to Katz et al.: The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva (Int J Radiat Oncol Biol Phys 2003;57:409-418). Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1635; author reply 1635-6. PMID: 15050345.
      Citations:    Fields:    Translation:HumansPHPublic Health
    110. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004 Mar 01; 22(5):872-80. PMID: 14990643.
      Citations: 211     Fields:    Translation:HumansCTClinical Trials
    111. Schimp VL, Worley C, Brunello S, Levenback CC, Wolf JK, Sun CC, Bodurka DC, Ramirez PT. Vacuum-assisted closure in the treatment of gynecologic oncology wound failures. Gynecol Oncol. 2004 Feb; 92(2):586-91. PMID: 14766251.
      Citations: 7     Fields:    Translation:Humans
    112. Pongtippan A, Malpica A, Levenback C, Deavers MT, Silva EG. Skene's gland adenocarcinoma resembling prostatic adenocarcinoma. Int J Gynecol Pathol. 2004 Jan; 23(1):71-4. PMID: 14668555.
      Citations: 4     Fields:    Translation:Humans
    113. Frumovitz M, Ramirez PT, Tortolero-Luna G, Malpica A, Eifel P, Burke TW, Levenback C. Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol. 2004 Jan; 92(1):205-10. PMID: 14751159.
      Citations: 3     Fields:    Translation:Humans
    114. Donato ML, Levenback C, Gershenson DM, McMeekin S, Champlin RE. Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report. Gynecol Oncol. 2004 Jan; 92(1):365-7. PMID: 14751187.
      Citations: 2     Fields:    Translation:Humans
    115. Follen M, Levenback CF, Iyer RB, Grigsby PW, Boss EA, Delpassand ES, Fornage BD, Fishman EK. Imaging in cervical cancer. Cancer. 2003 Nov 01; 98(9 Suppl):2028-38. PMID: 14603539.
      Citations: 20     Fields:    Translation:Humans
    116. Chung L, Broaddus R, Crozier M, Luthraa R, Levenback C, Lu K. Unexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancer. Obstet Gynecol. 2003 Nov; 102(5 Pt 2):1152-5. PMID: 14607039.
      Citations: 6     Fields:    Translation:Humans
    117. Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):409-18. PMID: 12957252.
      Citations: 11     Fields:    Translation:Humans
    118. Ramirez PT, Wolf JK, Levenback C. Laparoscopic port-site metastases: etiology and prevention. Gynecol Oncol. 2003 Oct; 91(1):179-89. PMID: 14529679.
      Citations: 29     Fields:    Translation:Humans
    119. Ramondetta LM, Burke TW, Jhingran A, Schmandt R, Bevers MW, Wolf JK, Levenback CF, Broaddus R. A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36. PMID: 13678720.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    120. Gordinier ME, Malpica A, Burke TW, Bodurka DC, Wolf JK, Jhingran A, Ramirez PT, Levenback C. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003 Sep; 90(3):625-8. PMID: 13678736.
      Citations: 7     Fields:    Translation:Humans
    121. Bodurka DC, Levenback C, Wolf JK, Gano J, Wharton JT, Kavanagh JJ, Gershenson DM. Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer. J Clin Oncol. 2003 Jan 15; 21(2):291-7. PMID: 12525521.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    122. Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002 Sep 01; 20(17):3651-7. PMID: 12202666.
      Citations: 34     Fields:    Translation:HumansPHPublic Health
    123. Barranger E, Grahek D, Cortez A, Uzan S, Darai E. Laparoscopic sentinel node procedure in patients with cervical cancer. J Clin Oncol. 2002 May 15; 20(10):2602-3; author reply 2603. PMID: 12011139.
      Citations: 1     Fields:    Translation:Humans
    124. Ramondetta LM, Silva EG, Levenback CF, Burke TW. Mixed choriocarcinoma in a postmenopausal patient. Int J Gynecol Cancer. 2002 May-Jun; 12(3):312-6. PMID: 12060455.
      Citations: 6     Fields:    Translation:HumansCells
    125. Dalrymple JL, Levenback C, Wolf JK, Bodurka DC, Garcia M, Gershenson DM. Trends among gynecologic oncology inpatient deaths: is end-of-life care improving? Gynecol Oncol. 2002 May; 85(2):356-61. PMID: 11972400.
      Citations: 1     Fields:    Translation:Humans
    126. Levenback C, Coleman RL, Burke TW, Lin WM, Erdman W, Deavers M, Delpassand ES. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002 Feb 01; 20(3):688-93. PMID: 11821449.
      Citations: 33     Fields:    Translation:Humans
    127. Verschraegen CF, Kavanagh JJ, Loyer E, Bodurka-Bevers D, Kudelka AP, Hu W, Vincent M, Nelson T, Levenback C. Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer. 2001 Nov 01; 92(9):2327-33. PMID: 11745287.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    128. Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001 Nov; 83(2):276-81. PMID: 11606084.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    129. Ramirez PT, Levenback C. Sentinel nodes in gynecologic malignancies. Curr Opin Oncol. 2001 Sep; 13(5):403-7. PMID: 11555721.
      Citations: 3     Fields:    Translation:Humans
    130. Donato ML, Gershenson DM, Wharton JT, Ippoliti CM, Aleman AS, Bodurka-Bevers D, Bevers MW, Burke TW, Levenback CF, Wolf JK, Freedman RS, Bast RC, Gajewski JL, Champlin RE. High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer. Gynecol Oncol. 2001 Sep; 82(3):420-6. PMID: 11520135.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    131. Ramirez PT, Levenback C, Burke TW, Eifel P, Wolf JK, Gershenson DM. Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol. 2001 Jul; 82(1):150-5. PMID: 11426977.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    132. Ramondetta L, Burke TW, Levenback C, Bevers M, Bodurka-Bevers D, Gershenson DM. Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol. 2001 Jul; 82(1):156-61. PMID: 11426978.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    133. Munkarah A, Levenback C, Wolf JK, Bodurka-Bevers D, Tortolero-Luna G, Morris RT, Gershenson DM. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Gynecol Oncol. 2001 May; 81(2):237-41. PMID: 11330956.
      Citations: 10     Fields:    Translation:HumansCells
    134. Muderspach LI, Blessing JA, Levenback C, Moore JL. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 2001 May; 81(2):213-5. PMID: 11354055.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    135. Ginsburg R, Bullard D, Eisenberg B, Gomella L, Johnstone D, Pisters PW, Sigurdson E, Weber R, Levenback C. Radiation Therapy Oncology Group. Research Plan 2002-2006. Surgical Oncology Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):92-5. PMID: 11641022.
      Citations:    Fields:    Translation:Humans
    136. Greven KM, Levenback C, Chao CK, Delaney T, Del Priore G, Eifel P, Erickson BA, Followill D, Gaffney D, Garcia M, Gerszten K, Grigsby P, Henderson R, Hricak H, Hsu J, Jhingrin A, Kaye A, Kudelka A, Lukka H, Mutch D, Nag S, Rotman M, Shefter T, Smith W, Stehman F, Souhami L, Wenzel L, Winter KA, Wolfson A. Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):58-9. PMID: 11641017.
      Citations:    Fields:    Translation:Humans
    137. Bodurka-Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR, Wharton JT. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol. 2000 Aug; 78(2):187-93. PMID: 10926801.
      Citations: 31     Fields:    Translation:HumansPHPublic Health
    138. Vang R, Medeiros LJ, Malpica A, Levenback C, Deavers M. Non-Hodgkin's lymphoma involving the vulva. Int J Gynecol Pathol. 2000 Jul; 19(3):236-42. PMID: 10907172.
      Citations: 4     Fields:    Translation:Humans
    139. Levenback C, Coleman RL, Ansink A, van der Zee AG. Re: Terada et al.: Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 76:40-44, 2000. Gynecol Oncol. 2000 Jun; 77(3):484-5. PMID: 10831370.
      Citations:    Fields:    Translation:Humans
    140. Donato ML, Gershenson D, Ippoliti C, Wharton JT, Bast RC, Aleman A, Anderlini P, Gajewski JG, Giralt S, Molldrem J, Ueno N, Lauppe J, Korbling M, Boyer J, Bodurka-Bevers D, Bevers M, Burke T, Freedman R, Levenback C, Wolf J, Champlin RE. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant. 2000 Jun; 25(11):1137-40. PMID: 10849525.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    141. Powell JL, Joseph DB. Abdominal sacral colpopexy in patients with gynecologic cancer and "Burch" not "Birch". Gynecol Oncol. 2000 Jun; 77(3):483-4. PMID: 10831367.
      Citations:    Fields:    Translation:Humans
    142. Levenback C. Intraoperative lymphatic mapping and sentinel node identification: gynecologic applications. Recent Results Cancer Res. 2000; 157:150-8. PMID: 10857169.
      Citations: 3     Fields:    Translation:Humans
    143. Verschraegen CF, Levenback C, Vincent M, Wolf J, Bevers M, Loyer E, Kudelka AP, Kavanagh JJ. Phase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan. Ann N Y Acad Sci. 2000; 922:349-51. PMID: 11193920.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    144. Gershenson DM, Morris M, Burke TW, Levenback C, Wolf J, Lee JJ, Thall PF, Atkinson EN, Silva EG, Wharton JT. A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma. Cancer. 1999 Dec 01; 86(11):2291-300. PMID: 10590370.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    145. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999 Apr 15; 340(15):1137-43. PMID: 10202164.
      Citations: 363     Fields:    Translation:HumansCTClinical Trials
    146. Wolf JK, Mullen J, Eifel PJ, Burke TW, Levenback C, Gershenson DM. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 1999 Apr; 73(1):35-41. PMID: 10094877.
      Citations: 11     Fields:    Translation:Humans
    147. Gershenson DM, Silva EG, Tortolero-Luna G, Levenback C, Morris M, Tornos C. Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer. 1998 Nov 15; 83(10):2157-63. PMID: 9827720.
      Citations: 19     Fields:    Translation:Humans
    148. Look KY, Blessing JA, Levenback C, Kohler M, Chafe W, Roman LD. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 1998 Sep; 70(3):334-8. PMID: 9790784.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    149. Levenback C. Should we accept mediocrity? N Engl J Med. 1998 Aug 27; 339(9):638. PMID: 9722447.
      Citations:    Fields:    Translation:Humans
    150. Morris M, Brader KR, Burke TW, Levenback CF, Gershenson DM. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix. Gynecol Oncol. 1998 Aug; 70(2):215-8. PMID: 9740693.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    151. Brader KR, Morris M, Levenback C, Levy L, Lucas KR, Gershenson DM. Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol. 1998 May; 16(5):1879-84. PMID: 9586904.
      Citations: 8     Fields:    Translation:Humans
    152. Morris M, Brader KR, Levenback C, Burke TW, Atkinson EN, Scott WR, Gershenson DM. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol. 1998 Mar; 16(3):1094-8. PMID: 9508195.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    153. Griffenberg L, Morris M, Atkinson N, Levenback C. The effect of dietary fiber on bowel function following radical hysterectomy: a randomized trial. Gynecol Oncol. 1997 Sep; 66(3):417-24. PMID: 9299255.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    154. Morris M, Levenback C, Burke TW, Dejesus Y, Lucas KR, Gershenson DM. An outcomes management program in gynecologic oncology. Obstet Gynecol. 1997 Apr; 89(4):485-92. PMID: 9083300.
      Citations: 3     Fields:    Translation:Humans
    155. Munkarah AR, Hallum AV, Morris M, Burke TW, Levenback C, Atkinson EN, Wharton JT, Gershenson DM. Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. Gynecol Oncol. 1997 Jan; 64(1):13-7. PMID: 8995541.
      Citations: 13     Fields:    Translation:Humans
    156. DiSaia PJ. What is the proper extent of an inguinal lymphadenectomy for early vulvar cancer? Gynecol Oncol. 1997 Jan; 64(1):183-5. PMID: 8995575.
      Citations:    Fields:    Translation:Humans
    157. Ratliff CR, Gershenson DM, Morris M, Burke TW, Levenback C, Schover LR, Mitchell MF, Atkinson EN, Wharton JT. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer. 1996 Nov 15; 78(10):2229-35. PMID: 8918419.
      Citations: 4     Fields:    Translation:Humans
    158. Levenback C, Burke TW, Rubin SC, Curtin JP, Wharton JT. Arterial occlusion complicating treatment of gynecologic cancer: a case series. Gynecol Oncol. 1996 Oct; 63(1):40-6. PMID: 8898166.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    159. Segreti EM, Morris M, Levenback C, Lucas KR, Gershenson DM, Burke TW. Transverse colon urinary diversion in gynecologic oncology. Gynecol Oncol. 1996 Oct; 63(1):66-70. PMID: 8898171.
      Citations: 1     Fields:    Translation:Humans
    160. Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol. 1996 Aug; 62(2):169-73. PMID: 8751545.
      Citations: 33     Fields:    Translation:Humans
    161. Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MF. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol. 1996 Jul; 88(1):82-6. PMID: 8684768.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    162. Levenback C, Morris M, Burke TW, Gershenson DM, Wolf JK, Wharton JT. Groin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol. 1996 Jul; 62(1):73-7. PMID: 8690296.
      Citations: 4     Fields:    Translation:Humans
    163. Levenback CF, Tortolero-Luna G, Pandey DK, Malpica A, Baker VV, Whittaker L, Johnson E, Follen Mitchell M. Uterine sarcoma. Obstet Gynecol Clin North Am. 1996 Jun; 23(2):457-73. PMID: 8784887.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    164. Kudelka AP, Tresukosol D, Edwards CL, Freedman RS, Levenback C, Chantarawiroj P, Gonzalez de Leon C, Kim EE, Madden T, Wallin B, Hord M, Verschraegen C, Raber M, Kavanagh JJ. Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma. J Clin Oncol. 1996 May; 14(5):1552-7. PMID: 8622071.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    165. Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996 Apr; 87(4):527-31. PMID: 8602303.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    166. Segreti EM, Levenback C, Morris M, Lucas KR, Gershenson DM, Burke TW. A comparison of end and loop colostomy for fecal diversion in gynecologic patients with colonic fistulas. Gynecol Oncol. 1996 Jan; 60(1):49-53. PMID: 8557227.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    167. Reddoch JM, Burke TW, Morris M, Tornos C, Levenback C, Gershenson DM. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol. 1995 Nov; 59(2):221-5. PMID: 7590477.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    168. Sweeten KM, Gershenson DM, Burke TW, Morris M, Levenback C, Silva EG. Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC). Gynecol Oncol. 1995 Nov; 59(2):211-5. PMID: 7590475.
      Citations: 2     Fields:    Translation:Humans
    169. Levenback C, Burke TW, Morris M, Malpica A, Lucas KR, Gershenson DM. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol. 1995 Nov; 59(2):216-20. PMID: 7590476.
      Citations: 9     Fields:    Translation:Humans
    170. Ripley D, Levenback C, Eifel P, Lewis RM. Adenocarcinoma of the cervix in a renal transplant patient. Gynecol Oncol. 1995 Oct; 59(1):151-5. PMID: 7557603.
      Citations: 3     Fields:    Translation:Humans
    171. Eifel PJ, Morris M, Burke TW, Levenback C, Gershenson DM. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 1995 Oct; 59(1):51-6. PMID: 7557615.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    172. Gershenson DM, Morris M, Burke TW, Levenback C, Kavanagh JJ, Fromm GL, Silva EG, Warner D, Wharton JT. Combined cisplatin and carboplatin chemotherapy for treatment of advanced epithelial ovarian cancer. Gynecol Oncol. 1995 Sep; 58(3):349-55. PMID: 7672700.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    173. Miller B, Morris M, Levenback C, Burke TW, Gershenson DM. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol. 1995 Aug; 58(2):202-5. PMID: 7622106.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    174. Chuang L, Burke TW, Tornos C, Marino BD, Mitchell MF, Tortolero-Luna G, Levenback C, Morris M, Gershenson DM. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol. 1995 Aug; 58(2):189-93. PMID: 7622103.
      Citations: 9     Fields:    Translation:Humans
    175. Eifel PJ, Levenback C, Wharton JT, Oswald MJ. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1995 Jul 30; 32(5):1289-300. PMID: 7635768.
      Citations: 51     Fields:    Translation:HumansPHPublic Health
    176. Crozier M, Morris M, Levenback C, Lucas KR, Atkinson EN, Wharton JT. Pelvic exenteration for adenocarcinoma of the uterine cervix. Gynecol Oncol. 1995 Jul; 58(1):74-8. PMID: 7789894.
      Citations: 2     Fields:    Translation:Humans
    177. Bicher A, Levenback C, Burke TW, Morris M, Warner D, DeJesus Y, Gershenson DM. Infusion site soft-tissue injury after paclitaxel administration. Cancer. 1995 Jul 01; 76(1):116-20. PMID: 8630862.
      Citations: 4     Fields:    Translation:Humans
    178. Bicher A, Levenback C, Silva EG, Burke TW, Morris M, Gershenson DM. Ovarian malignant mixed müllerian tumors treated with platinum-based chemotherapy. Obstet Gynecol. 1995 May; 85(5 Pt 1):735-9. PMID: 7724104.
      Citations: 4     Fields:    Translation:Humans
    179. Burke TW, Morris M, Roh MS, Levenback C, Gershenson DM. Perineal reconstruction using single gracilis myocutaneous flaps. Gynecol Oncol. 1995 May; 57(2):221-5. PMID: 7729738.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    180. Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995 May; 57(2):215-20. PMID: 7729737.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    181. Morris M, Eifel PJ, Burke TW, McNamara MM, Levenback C, Kavanagh JJ, Gershenson DM. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol. 1995 Apr; 57(1):72-8. PMID: 7705704.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    182. Miller B, Morris M, Gershenson DM, Levenback CL, Burke TW. Intestinal fistulae formation following pelvic exenteration: a review of the University of Texas M. D. Anderson Cancer Center experience, 1957-1990. Gynecol Oncol. 1995 Feb; 56(2):207-10. PMID: 7896187.
      Citations: 6     Fields:    Translation:Humans
    183. McIntyre JF, Eifel PJ, Levenback C, Oswald MJ. Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer. 1995 Feb 01; 75(3):836-43. PMID: 7828135.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    184. Lehman E, Gershenson DM, Burke TW, Levenback C, Silva EG, Morris M. Salvage surgery for chemorefractory gestational trophoblastic disease. J Clin Oncol. 1994 Dec; 12(12):2737-42. PMID: 7989951.
      Citations: 8     Fields:    Translation:Humans
    185. Burke TW, Morris M, Levenback C, Gershenson DM, Wharton JT. Closure of complex vulvar defects using local rhomboid flaps. Obstet Gynecol. 1994 Dec; 84(6):1043-7. PMID: 7970463.
      Citations: 1     Fields:    Translation:Humans
    186. Munkarah A, Gershenson DM, Levenback C, Silva EG, Messing MJ, Morris M, Burke TW. Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol. 1994 Nov; 55(2):217-23. PMID: 7959287.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    187. Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994 Nov; 55(2):206-10. PMID: 7959285.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    188. Burke TW, Gershenson DM, Morris M, Stringer CA, Levenback C, Tortolero-Luna G, Baker VV. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol. 1994 Oct; 55(1):47-50. PMID: 7959265.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    189. Heitjan DF. The NSABP trials. N Engl J Med. 1994 Sep 22; 331(12):809-10. PMID: 8065416.
      Citations:    Fields:    Translation:Humans
    190. Levenback C. The NSABP trials. N Engl J Med. 1994 Sep 22; 331(12):809. PMID: 8065415.
      Citations:    Fields:    Translation:Humans
    191. Zimecki MW. . . . and how the decisions are made. N Engl J Med. 1994 Aug 04; 331(5):331; author reply 332. PMID: 8022455.
      Citations:    Fields:    Translation:Humans
    192. Levenback C. . . . and how the decisions are made. N Engl J Med. 1994 Aug 04; 331(5):331; author reply 332. PMID: 8022454.
      Citations:    Fields:    Translation:Humans
    193. Levenback C, Burke TW, Gershenson DM, Morris M, Malpica A, Ross MI. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol. 1994 Aug; 84(2):163-7. PMID: 8041523.
      Citations: 23     Fields:    Translation:Humans
    194. Levenback C. Gynecologic oncology: a review for ET nurses. J Wound Ostomy Continence Nurs. 1994 Jul; 21(4):141-8. PMID: 8055068.
      Citations:    Fields:    Translation:HumansPHPublic Health
    195. Segreti EM, Munkarah A, Levenback C. Successful percutaneous drainage of gluteal pyomyositis occurring after intra-arterial chemotherapy and pelvic irradiation. Gynecol Oncol. 1994 Jun; 53(3):376-9. PMID: 8206415.
      Citations:    Fields:    Translation:Humans
    196. Morris M, Gershenson DM, Burke TW, Mitchell MF, Levenback C, Atkinson N, Wharton JT. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix. Gynecol Oncol. 1994 May; 53(2):234-8. PMID: 8188085.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    197. Umpierre SA, Burke TW, Tornos C, Ordonez N, Levenback C, Morris M. Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors. Int J Gynecol Pathol. 1994 Apr; 13(2):127-30. PMID: 8005733.
      Citations: 1     Fields:    Translation:Humans
    198. Levenback C, Gershenson DM, McGehee R, Eifel PJ, Morris M, Burke TW. Enterovesical fistula following radiotherapy for gynecologic cancer. Gynecol Oncol. 1994 Mar; 52(3):296-300. PMID: 8157186.
      Citations: 3     Fields:    Translation:Humans
    199. Levenback C, Curtin J, Johnston D, Rubin SC, Yeh S, Hoskins W. Image analysis of the distribution of intraperitoneally administered fluids in patients with ovarian cancer. Eur J Gynaecol Oncol. 1994; 15(5):345-51. PMID: 7828603.
      Citations: 1     Fields:    Translation:Humans
    200. Burke TW, Munkarah A, Kavanagh JJ, Morris M, Levenback C, Tornos C, Gershenson DM. Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin. Gynecol Oncol. 1993 Dec; 51(3):397-400. PMID: 8112651.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    201. Levenback C. Effects of early postoperative chemotherapy on wound healing. Obstet Gynecol. 1992 Oct; 80(4):730. PMID: 1407906.
      Citations:    Fields:    Translation:Humans
    202. Levenback C, Burke TW, Silva E, Morris M, Gershenson DM, Kavanagh JJ, Wharton JT. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol. 1992 Sep; 46(3):317-21. PMID: 1526508.
      Citations: 16     Fields:    Translation:Humans
    203. Levenback C, Dershaw DD, Rubin SC. Endoluminal ultrasound staging of cervical cancer. Gynecol Oncol. 1992 Aug; 46(2):186-90. PMID: 1500021.
      Citations:    Fields:    Translation:Humans
    204. Levenback C, Rubin SC, McCormack PM, Hoskins WJ, Atkinson EN, Lewis JL. Resection of pulmonary metastases from uterine sarcomas. Gynecol Oncol. 1992 May; 45(2):202-5. PMID: 1592288.
      Citations: 14     Fields:    Translation:Humans
    205. Survival of patients with metastatic leiomyosarcoma. Cancer Medicine. 5:3437-3444.
    206. Lymphatic Mapping of the Female Genital Tract. 649-663.
    207. Collaborative relationship building top ten strategies to engage physicians. Journal of Gynecologic Oncology Nursing. 19:31-35.
    208. Anatomic distribution of [18F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Practical Radiation Oncology. 3:45-53.
    209. 4th International Conference on Cervical Cancer. Gynecologic Oncology. 99.
    210. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Obstetrical and Gynecological Survey. 68:439-440.
    211. The DISINFECT Initiative. Annals of Surgical Oncology. 1-7.
    212. What is the real rate of surgical site infection?. Journal of Oncology Practice. 12:e878-e883.
    213. STUMP un"stumped". Journal of Hematology and Oncology. 8.
    214. Complications of radiotherapy for treatment of cervix cancer. Clinical Consultations in Obstetrics and Gynecology. 7:152-159.
    215. Fighting cancer together. Gynecologic Oncology. 140:114-119.
    216. Gynecologic malignancy. 447-452.
    217. Pelvic irradiation with concurrent chemotherapy versus pelvic for high-risk cervical cancer. Women's Oncology Review. 4:127-128.
    218. Vulva. 524-544.
    219. Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin. Journal of Translational Medicine. 4.
    220. Use of CA-125 tests and computed tomographic scans for surveillance in ovarian cancer. Obstetrical and Gynecological Survey. 71:660-661.
    221. Intraoperative lymphatic mapping for vulvar cancer. ACOG Current Journal Review. 8:41.
    222. Cervical cancer. 97-107.
    223. Use and effectiveness of neoadjuvant chemotherapy for treatment of ovarian cancer. Journal of Clinical Oncology. 34:3854-3863.
    LEVENBACK's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (496)
    Explore
    _
    Co-Authors (90)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _